Cittadine Andrew
Insider CIK 1863624 · MNPR Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-09-30 | 2026-10-02 | 4,384 | — | $0 | 35,115 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2026-09-30 | 2026-10-02 | 1,944 | $79.67 | $154.9K | 58,054 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-09-30 | 2026-10-02 | 4,384 | — | — | 59,998 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-06-30 | 2026-07-02 | 5,254 | — | $0 | 39,499 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-06-30 | 2026-07-02 | 5,254 | — | $0 | 57,923 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2026-06-30 | 2026-07-02 | 2,309 | $92.59 | $213.8K | 55,614 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-03-31 | 2026-04-02 | 3,514 | — | $0 | 44,753 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-03-31 | 2026-04-02 | 3,514 | — | $0 | 54,240 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2026-03-31 | 2026-04-02 | 1,571 | $54.79 | $86.1K | 52,669 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2025-12-31 | 2026-01-05 | 4,326 | — | $0 | 48,267 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-12-31 | 2026-01-05 | 1,889 | $65.30 | $123.4K | 50,726 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-12-31 | 2026-01-05 | 4,326 | — | $0 | 52,615 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-12-02 | 2025-12-08 | 13,919 | — | $0 | 52,593 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-12-02 | 2025-12-08 | 8,969 | — | $0 | 8,969 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2025-09-30 | 2025-10-02 | 4,327 | — | $0 | 38,674 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-09-30 | 2025-10-02 | 1,896 | $81.67 | $154.8K | 48,289 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-09-30 | 2025-10-02 | 4,327 | — | $0 | 50,185 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2025-06-30 | 2025-07-02 | 6,863 | — | $0 | 43,001 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-06-30 | 2025-07-02 | 6,863 | — | $0 | 48,848 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-06-30 | 2025-07-02 | 2,990 | $35.78 | $107.0K | 45,858 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-03-31 | 2025-04-02 | 744 | $36.41 | $27.1K | 41,985 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-03-31 | 2025-04-02 | 1,791 | — | $0 | 42,729 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-03-04 | 2025-03-07 | 40,581 | — | $0 | 51,655 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-03-04 | 2025-03-07 | 43,445 | — | $0 | 43,445 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-12-31 | 2025-01-02 | 1,790 | — | $0 | 11,074 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-12-31 | 2025-01-02 | 721 | $22.00 | $15.9K | 40,938 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-12-31 | 2025-01-02 | 1,790 | — | $0 | 41,659 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-09-30 | 2024-10-02 | 1,791 | — | $0 | 12,864 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-09-30 | 2024-10-02 | 535 | $6.74 | $3.6K | 39,869 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-09-30 | 2024-10-02 | 1,791 | — | $0 | 40,404 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-06-30 | 2024-07-02 | 8,952 | — | $0 | 73,271 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-06-30 | 2024-07-02 | 8,952 | — | $0 | 195,084 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-06-30 | 2024-07-02 | 2,019 | $0.73 | $1.5K | 193,065 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-06-20 | 2024-06-21 | 20,508 | $0.74 | $15.2K | 186,132 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-06-18 | 2024-06-21 | 12,000 | $0.86 | $10.3K | 165,624 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-06-17 | 2024-06-17 | 12,000 | $0.90 | $10.8K | 153,624 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-06-14 | 2024-06-17 | 12,000 | $0.93 | $11.2K | 141,624 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-06-13 | 2024-06-17 | 12,000 | $0.91 | $10.9K | 129,624 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-06-04 | 2024-06-05 | 12,000 | $0.78 | $9.4K | 117,624 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-06-03 | 2024-06-05 | 12,000 | $0.76 | $9.1K | 105,624 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-05-31 | 2024-05-31 | 12,000 | $0.64 | $7.7K | 93,624 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-05-30 | 2024-05-31 | 12,000 | $0.64 | $7.7K | 81,624 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2024-05-29 | 2024-05-31 | 12,000 | $0.64 | $7.7K | 69,624 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2024-05-22 | 2024-05-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-03-31 | 2025-04-02 | 1,791 | — | $0 | 49,864 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-03-31 | 2024-04-02 | 8,952 | — | $0 | 82,223 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-03-31 | 2024-04-02 | 3,098 | $0.68 | $2.1K | 57,624 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-03-31 | 2024-04-02 | 8,952 | — | $0 | 60,722 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-12-31 | 2024-01-03 | 8,952 | — | $0 | 91,175 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-12-31 | 2024-01-03 | 3,098 | $0.34 | $1.1K | 51,770 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-12-31 | 2024-01-03 | 8,952 | — | $0 | 54,868 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-09-30 | 2023-10-03 | 8,953 | — | $0 | 100,127 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-09-30 | 2023-10-03 | 2,624 | $0.62 | $1.6K | 45,916 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-09-30 | 2023-10-03 | 8,953 | — | $0 | 48,540 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-06-30 | 2023-07-03 | 13,841 | — | $0 | 109,080 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-06-30 | 2023-07-03 | 13,841 | — | $0 | 43,644 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-06-30 | 2023-07-03 | 4,057 | $0.86 | $3.5K | 39,587 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-03-31 | 2023-04-04 | 4,063 | — | $0 | 44,687 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-03-31 | 2023-04-04 | 1,154 | $1.39 | $1.6K | 29,803 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-03-31 | 2023-04-04 | 4,063 | — | $0 | 30,957 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2023-02-01 | 2023-02-03 | 102,688 | — | $0 | 102,688 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2023-02-01 | 2023-02-03 | 78,234 | — | $0 | 126,984 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-12-31 | 2023-01-03 | 4,062 | — | $0 | 48,750 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-12-31 | 2023-01-03 | 1,406 | $2.37 | $3.3K | 26,894 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-12-31 | 2023-01-03 | 4,062 | — | $0 | 28,300 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2022-11-15 | 2022-11-16 | 10,000 | $3.15 | $31.5K | 24,238 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2022-11-14 | 2022-11-16 | 6,053 | $3.00 | $18.2K | 14,238 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-09-30 | 2022-10-03 | 4,063 | — | $0 | 52,812 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-09-30 | 2022-10-03 | 1,191 | $1.52 | $1.8K | 8,185 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-09-30 | 2022-10-03 | 4,063 | — | $0 | 9,376 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-06-30 | 2022-07-01 | 8,125 | — | $0 | 56,875 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-06-30 | 2022-07-01 | 8,125 | — | $0 | 8,125 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-06-30 | 2022-07-01 | 2,812 | $2.30 | $6.5K | 5,313 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 85,000 | — | $0 | 85,000 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-06-30 | 2021-07-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-06-01 | 2021-06-02 | 70,000 | — | $0 | 70,000 | SEC↗ |